Dag K Von Lubitz

Title: Dag K Von Lubitz: Innovator in A3 Adenosine Receptor Agonists

Introduction

Dag K Von Lubitz is a notable inventor based in Alexandria, VA (US). He has made significant contributions to the field of pharmacology, particularly in the development of compounds that selectively activate A3 adenosine receptors. His work has implications for various therapeutic applications.

Latest Patents

Dag K Von Lubitz holds 1 patent related to A3 adenosine receptor agonists. The patent describes N.sup.6-benzyladenosine-5'-N-uronamide and related substituted compounds. These compounds contain substituents on the benzyl and/or uronamide groups, as well as modified xanthine ribosides. The invention also outlines a method for selectively activating an A.sub.3 adenosine receptor in mammals. This method involves administering a therapeutically effective amount of a compound that binds to the A.sub.3 receptor, stimulating an A.sub.3 receptor-dependent response.

Career Highlights

Dag K Von Lubitz is associated with the United States of America as represented by the Department of Health. His work has been instrumental in advancing the understanding of adenosine receptors and their potential therapeutic uses.

Collaborations

He has collaborated with notable colleagues, including Kenneth Alan Jacobson and Carola Gallo-Rodriguez. Their combined expertise has contributed to the success of their research endeavors.

Conclusion

Dag K Von Lubitz is a prominent figure in the field of pharmacology, with a focus on A3 adenosine receptor agonists. His innovative work continues to pave the way for new therapeutic approaches.